Ignite Creation Date:
2024-07-17 @ 11:04 AM
Last Modification Date:
2024-10-26 @ 3:34 PM
Study NCT ID:
NCT06493279
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-07-09
First Post:
2024-07-02
Brief Title:
Evaluate the Safety and Efficacy of Intrathecal Injection of RJK002 in Patients With Amyotrophic Lateral Sclerosis
Sponsor:
Rejukon Biopharm Inc
Organization:
Rejukon Biopharm Inc
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Amyotrophic Lateral Sclerosis Als |
Keywords: